ATE535233T1 - DRY POWDER COMPOSITION WITH CO-JET GROUND PARTICLES FOR PULMONARY INHALATION - Google Patents
DRY POWDER COMPOSITION WITH CO-JET GROUND PARTICLES FOR PULMONARY INHALATIONInfo
- Publication number
- ATE535233T1 ATE535233T1 AT04768542T AT04768542T ATE535233T1 AT E535233 T1 ATE535233 T1 AT E535233T1 AT 04768542 T AT04768542 T AT 04768542T AT 04768542 T AT04768542 T AT 04768542T AT E535233 T1 ATE535233 T1 AT E535233T1
- Authority
- AT
- Austria
- Prior art keywords
- dry powder
- powder composition
- ground particles
- pulmonary inhalation
- jet ground
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C19/00—Other disintegrating devices or methods
- B02C19/06—Jet mills
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0321607.4A GB0321607D0 (en) | 2003-09-15 | 2003-09-15 | Manufacture of pharmaceutical compositions |
PCT/GB2004/003996 WO2005025536A2 (en) | 2003-09-15 | 2004-09-15 | Dry powder composition comprising co-jet milled particles for pulmonary inhalation |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE535233T1 true ATE535233T1 (en) | 2011-12-15 |
Family
ID=45217849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04768542T ATE535233T1 (en) | 2003-09-15 | 2004-09-15 | DRY POWDER COMPOSITION WITH CO-JET GROUND PARTICLES FOR PULMONARY INHALATION |
Country Status (5)
Country | Link |
---|---|
AT (1) | ATE535233T1 (en) |
CY (1) | CY1112389T1 (en) |
ES (2) | ES2377205T3 (en) |
HK (1) | HK1092068A1 (en) |
SI (1) | SI1663155T1 (en) |
-
2004
- 2004-09-15 AT AT04768542T patent/ATE535233T1/en active
- 2004-09-15 SI SI200431830T patent/SI1663155T1/en unknown
- 2004-09-15 ES ES04768542T patent/ES2377205T3/en active Active
- 2004-09-15 ES ES10181354.1T patent/ES2671546T3/en active Active
-
2006
- 2006-12-06 HK HK06113397.6A patent/HK1092068A1/en unknown
-
2012
- 2012-02-23 CY CY20121100187T patent/CY1112389T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CY1112389T1 (en) | 2015-12-09 |
ES2671546T3 (en) | 2018-06-07 |
HK1092068A1 (en) | 2007-02-02 |
SI1663155T1 (en) | 2012-07-31 |
ES2377205T3 (en) | 2012-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1663155T3 (en) | Dry powder composition comprising co-jet milled particles for pulmonary inhalation | |
CY2014015I2 (en) | METHODS OF PREPARATION OF DRY POWDER COMPOSITIONS OF GLYCOPYRROLIC | |
IL179488A0 (en) | Dry powder inhaler | |
NO20082488A (en) | Powder mixtures for inhalation | |
DE60212884D1 (en) | dry powder inhaler | |
IL184111A0 (en) | Prostaglandin-containing compositions and methods for enhancing the stability thereof | |
PT1855652E (en) | Drying of drug-containing particles | |
EP1883389A4 (en) | Low-irritation compositions and methods of making the same | |
IL199006A0 (en) | Nanoparticulate formulations and methods for the making and use thereof | |
EP1838165A4 (en) | Methods for enhancing the palatability of compositions for consumption by animals | |
IL174735A (en) | Dry powder inhaler | |
EP1824466A4 (en) | Compositions and methods for pulmonary conditions | |
GB0500677D0 (en) | Dry powder inhaler | |
DE602004025463D1 (en) | USE OF CICLESONIDE FOR THE CONSERVATION OF THE FINE PARTICLE PROPORTION OF FORMOTEROL | |
IS7501A (en) | dry powder inhalation composition | |
GB0416328D0 (en) | Use of dry powder compositions for pulmonary delivery | |
ZA200805711B (en) | Solid biocidal compositions and methods of using the same | |
GB0516880D0 (en) | Artificial turf | |
EP1765331A4 (en) | Methods and compositions for the treatment of pulmonary diseases | |
ZA200705095B (en) | Methods for enchanging the palatability of food compositions | |
DK1545634T3 (en) | Process for the preparation of dry powder inhalation compositions | |
GB0321610D0 (en) | Dry powder inhaler | |
ATE535233T1 (en) | DRY POWDER COMPOSITION WITH CO-JET GROUND PARTICLES FOR PULMONARY INHALATION | |
EP2107904A4 (en) | Compositions for the reversal and detoxification of anesthetics and other compounds and methods of their use | |
FI20030315A0 (en) | Methods and constructions for increasing the content of selected amino acids in seeds |